You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Causative pathogens identified at pretherapy/entry in the per-protocol bacteriologically evaluable (PPb) and bacteriologic modified intent to treat (bmITT) populations.

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Pathogen Number of Isolates in PPb Patients Number of Isolates in bmITT Patients
Total 204 337
S pneumoniae 57 76
H influenzae 49 88
H parainfluenzae 46 81
M catarrhalis 13 23
K pneumoniae 3 9
S aureus 15 23
Other* 21 37
  1. *Includes: Haemophilus haemolyticus (7); Haemophilus parahaemolyticus (7); Enterobacter cloacae (4); Pseudomonas aeruginosa (4); Acinetobacter baumannii (1 bmITT only); Citrobacter freundii (1 bmITT only); Enterobacter aerogenes (1); Enterobacter agglomerans (1 bmITT only); Enterobacter amnigenus (1 bmITT only); Enterobacter not otherwise specified (NOS) (1 bmITT only); Neisseria meningitides (1); Proteus mirabilis (1); Proteus NOS (1 bmITT only); Streptococcus, viridansgroup(5); Staphylococcus haemolyticus (1).